Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hercules Capital is a leading specialty finance company that provides venture debt and equity to venture-backed companies in the technology, life sciences, and sustainable technology sectors. Formerly known as Hercules Technology Growth Capital, the firm operates as a Business Development Company (BDC) and is a prominent financier in the biopharmaceutical and medical device industries. It offers non-dilutive capital to support clinical trials, commercialization efforts, and strategic growth for its portfolio companies. Since its inception, Hercules has committed over $20 billion in capital to more than 600 companies, making it a critical component of the life sciences innovation ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hercules Technology.